1 ENGR OSSED HOUSE
BILL NO. 2801 By: Marti of the House
2
and
3
Stanley of the Senate
4
5
6
7 [ antipsychotic drugs - vendor drug program â€“
8 disorders - prior authorization - effective date ]
9
10
11 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
12 SECTION 1. AMENDATORY 56 O.S. 2021, Section 204, is
13 amended to read as follows:
14 Section 204. A. Except as otherwise provided, the Oklahoma
15 Health Care Authority shall be authorized and directed to establish
16 a vendor drug program to provide any drugs that have been approved
17 and designated as safe and effective by the federal Food and Drug
18 Administration, and that are prescribed by a licensed medical,
19 dental, podiatric, or osteopathic practitioner for eligible
20 recipients of assistance payments suffering from painful or life-
21 endangering diseases or other persons who are suffering from a
22 catastrophic illness.
23 B. The Authority shall, in accordance with federal law, not be
24 obligated to cover any outpatient drugs of a manufacturer which has
ENGR. H. B. NO. 2801 Page 1

1 not entered into or which does not have in effect a rebate agreement
2 with the Secretary of Health and Human Services on behalf of the
3 state.
4 C. Such program shall, to the fullest extent possible, be
5 established and maintained in conjunction with existing federal
6 programs of prescribed drugs so as to earn the maximum of federal
7 financial participation. Exempt from the provisions of this section
8 are the following drugs or classes of drugs, or their medical uses:
9 1. Agents when used for anorexia or weight gain;
10 2. Agents when used to promote fertility;
11 3. Agents when used for cosmetic purposes or hair growth;
12 4. Agents when used for the symptomatic relief of coughs and
13 colds;
14 5. Agents when used to promote smoking cessation;
15 6. Prescription vitamins and mineral products, except prenatal
16 vitamins and fluoride preparations;
17 7. Nonprescription drugs;
18 8. Covered outpatient drugs when the manufacturer seeks to
19 require as a condition of sale that associated tests or monitoring
20 services be purchased exclusively from the manufacturer or its
21 designee;
22 9. Drugs described in paragraph 3 of subsection c of Section
23 107 of the Drug Amendments of 1962, 21 U.S.C., Section 107(c)(3),
24 and identical, similar or related drugs, within the meaning of
ENGR. H. B. NO. 2801 Page 2

1 para graph 1 of subsection b of Section 310.6 of Title 21 of the Code
2 of Federal Regulations;
3 10. Barbiturates; or
4 11. Benzodiazepines;
5 provided, however, the Authority shall be authorized to include
6 specific drugs within these categories for reimbursement based upon
7 specific medical need.
8 D. The Authority shall be authorized to establish a prospective
9 drug utilization review program for the H2 Antagonists; provided
10 that such limitations are in compliance with federal Food and Drug
11 Administration Agency-approved product labeling.
12 E. The Authority shall approve a prior authorization request
13 for any Food and Drug Administration approved atypical antipsychotic
14 that is not on the preferred drug list for the treatment and
15 prevention of mood disorders with psychotic symptoms including
16 bipolar disorders, schizophrenia, and schizotypal or delusion
17 disorders. Medications included under this section shall be
18 available at parity to other branded medications in the same class.
19 Approval shall be based on patient's claims history or health care
20 provider attestation of one of the following conditions for the
21 Medicaid client:
22 1. A trial and failure of any preferred atypical antipsychotic
23 in the preceding three hundred sixty-five (365) days; or
24
ENGR. H. B. NO. 2801 Page 3

1 2. The patient is stable on an atypical antipsychotic that is
2 not included on the preferred drug list.
3 SECTION 2. This act shall become effective November 1, 2025.
4 Passed the House of Representatives the 10th day of March, 2025.
5
6
Presiding Officer of the House
7 of Representatives
8
Passed the Senate the ___ day of __________, 2025.
9
10
11 Presiding Officer of the Senate
12
13
14
15
16
17
18
19
20
21
22
23
24
ENGR. H. B. NO. 2801 Page 4

[DELETED:  P B M   a S]
[DELETED:  P]
[DELETED:  P]
[DELETED:  PPoP]